ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 761

Protein/Creatinin Urinary Index Has Concordance with 24 Hour Urinary Proteinuria in Patients with Systemic Lupus Erythematosus

Eugenia Picco1, Ricardo Vicente Juárez2, Emilio Buschiazzo2, Natalia Lili Cucchiaro3, Gustavo Rua4, Patricia Talocchino1, Ivana Romina Rojas Tessel1, Mariana Aciar3, Maria Veronica Lencina3 and Maria Elena Crespo Espindola5, 1Hospital Señor del Milagro, Salta, Argentina, 2Rheumatology Section, Hospital Señor del Milagro, Salta, Argentina, 3Rheumatology, Hospital Señor del Milagro, Salta, Argentina, 4Biochemistry Section, Hospital Señor del Milagro, Salta, Argentina, 5Reumatologia, Hospital Señor del Milagro, Salta, Argentina

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: proteinuria and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Twenty-four hour proteinuria (24hp) has been the gold standard for the screening and follow up of glomerular disease. The use of protein/creatinin urinary index (PCI) in a spot urine sample, has been proposed as an alternative to 24hp due to its low cost and simple recollection of the sample. This method has been validated in patients with diabetic and non-diabetic nephropathy, with less data in patients with Systemic Lupus Erythematosus (SLE). The aim of this study was to measure the correlation and concordance between this two methods in patients with SLE

Methods: Paired samples of 24hp (in grams in 24 hours) and PCI (first urine sample, expressed in mg/g) in SLE diagnosed patients with or without lupus nephropathy, collected between June 2015 and May 2018, in Señor del Milagro’s Hospital at Rheumatology Unit were included for the analysis. PCI value is 1000 times higher than 24hp. Walser’s index (WI) which evaluates the quality of the collected sample on 24hp, calculated with estimated and measured urine creatinine, age and weight was performed. A WI between 0.75 to 1.25 reflects well collected 24hp. Qualitative data was expressed in frequency and percentages, quantitative data in medians and interquartile range (IQR) or media and standard deviation (SD) depending on its distribution. Spearman test was performed to assess correlation between 24hp ande PCI was. In order to analyze concordance between PCI and 24hp, the PCI was multiplied by 1000. Interclass Concordance Coefficient (ICC), with (crohnbach’s alpha) was calculated. Receiver operating curves (ROC) with under the curve area (UCA) were calculated for 24hp values of ≥ 0.3, 0.5, 1 and 3.5 grams per 24 hours, in order to calculate IPC cutpoints. A p value < 0.05 was considered significative.

Results: 68 patients, 60 (88.2) female, median age 33 years (IQR: 27-48), and 187 paired urine samples were included. Spearman’s correlation between the 2 methods was 0.84. ICC was > 0.9 for the whole sample, 0.92 when WI was acceptable (n=88) and only dropped to 0.88 in the context of “non-acceptable” WI (n=99). Considering only acceptable WI samples, ROC curves showed cutpoints of 333 mg/g, 407 mg/g, 984 mg/g and 3013 mg/g had good sensitivity and specificity (S 77, Sp 87 or higher) to predict 24hp of 0.3 g, 0.5 g, 1 g and 3.5 g.

Conclusion: In this sample of SLE patients, 24ph and PCI had a good ICC and correlation, considering an acceptable WI. The use of PCI could replace 24ph in the assessment of glomerular disease in SLE patients.


Disclosure: E. Picco, None; R. V. Juárez, None; E. Buschiazzo, None; N. L. Cucchiaro, None; G. Rua, None; P. Talocchino, None; I. R. Rojas Tessel, None; M. Aciar, None; M. V. Lencina, None; M. E. Crespo Espindola, None.

To cite this abstract in AMA style:

Picco E, Juárez RV, Buschiazzo E, Cucchiaro NL, Rua G, Talocchino P, Rojas Tessel IR, Aciar M, Lencina MV, Crespo Espindola ME. Protein/Creatinin Urinary Index Has Concordance with 24 Hour Urinary Proteinuria in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/protein-creatinin-urinary-index-has-concordance-with-24-hour-urinary-proteinuria-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/protein-creatinin-urinary-index-has-concordance-with-24-hour-urinary-proteinuria-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology